DR. STANLEY W. CHAPMAN, MD
Osteopathic Medicine at State St, Jackson, MS
License number
Mississippi 08888
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
2500 NORTH State St, Jackson, MS 39216
Phone
(601) 984-5560
(601) 984-5565 (Fax)
(601) 984-5565 (Fax)
Personal information
See more information about STANLEY W. CHAPMAN at radaris.comName
Address
Phone
9128 Forrest Dr, Southaven, MS 38671
9128 Forrest Dr, Southaven, MS 38671
Professional information
Stanley W Chapman, Jackson MS
Specialties:
Infectious Disease Specialist
Address:
2500 N State St, Jackson, MS 39216
Education:
University of Rochester, School of Medicine and Dentistry - Doctor of Medicine
Strong Memorial Hospital - Fellowship - Infectious Disease (Internal Medicine)
National Institutes of Health-Clinical Center - Fellowship - Allergy and Immunology
Emory University Hospital - Residency - Family Medicine
Strong Memorial Hospital - Fellowship - Infectious Disease (Internal Medicine)
National Institutes of Health-Clinical Center - Fellowship - Allergy and Immunology
Emory University Hospital - Residency - Family Medicine
Board certifications:
American Board of Allergy and Immunology Certification in Allergy and Immunology, American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Dr. Stanley W Chapman - MD (Doctor of Medicine)
Hospitals:
UNIVERSITY-MISSISSIPPI MED CTR
2500 N State St, Jackson 39216
UNIVERSITY MEDICAL CENTER
2500 N State St, Jackson 39216
Jackson Office
2500 N State St, Jackson 39216
UNIVERSITY-MISSISSIPPI MED CTR
2500 N State St, Jackson 39216
UNIVERSITY MEDICAL CENTER
2500 N State St, Jackson 39216
Jackson Office
2500 N State St, Jackson 39216
2500 N State St, Jackson 39216
UNIVERSITY MEDICAL CENTER
2500 N State St, Jackson 39216
Jackson Office
2500 N State St, Jackson 39216
UNIVERSITY-MISSISSIPPI MED CTR
2500 N State St, Jackson 39216
UNIVERSITY MEDICAL CENTER
2500 N State St, Jackson 39216
Jackson Office
2500 N State St, Jackson 39216
Education:
Medical Schools
University of Rochester
Graduated: 1972
University of Rochester
Graduated: 1972
Compositions Comprising Highly Purified Amphotericin B
US Patent:
2006010, May 18, 2006
Filed:
Oct 3, 2003
Appl. No.:
10/529622
Inventors:
John Cleary - BRANDON MS, US
Stanley Chapman - Jackson MS, US
Robert Kramer - Brandon MS, US
Stanley Chapman - Jackson MS, US
Robert Kramer - Brandon MS, US
International Classification:
A61K 31/7048
US Classification:
514028000
Abstract:
A method for treating fungal infections in a mammal that comprises administering a therapeutically effective amount of a composition comprising amphotericin B and a pharmaceutically acceptable carrier, wherein the amphotericin B is substantially pure.
Use Of Il-2 Receptor Antibodies
US Patent:
2004011, Jun 17, 2004
Filed:
Oct 1, 2003
Appl. No.:
10/677148
Inventors:
Stanley Chapman - Jackson MS, US
John Cleary - Brandon MS, US
Robert Gordon - Atlanta GA, US
John Cleary - Brandon MS, US
Robert Gordon - Atlanta GA, US
International Classification:
A61K039/00, A61K039/38
US Classification:
424/184100
Abstract:
The invention relates to a method for treating a patient having a fungal infection. The invention comprises administering to the patient a therapeutically effective amount of a polyene antifungal (e.g., amphotericin B) in association with a therapeutically effective amount of a interleukin-2 inhibitor (e.g., chimeric or humanized monoclonal antibody that binds to the p55 subunit of the human interleukin-2 receptor and inhibits binding of interleukin-2 to an interleukin-2 receptor).
Methods And Formulations For Reducing Amphotericin B Treatment Side Effects
US Patent:
8648050, Feb 11, 2014
Filed:
Jan 5, 2011
Appl. No.:
12/985256
Inventors:
John D. Cleary - Brandon MS, US
Stanley W. Chapman - Jackson MS, US
Robert E. Kramer - Brandon MS, US
Stanley W. Chapman - Jackson MS, US
Robert E. Kramer - Brandon MS, US
Assignee:
University of Mississippi - University MS
International Classification:
A61K 31/70, C07H 17/08
US Classification:
514 31, 536 65
Abstract:
A method of ameliorating amphotericin treatment side effects in a mammal that comprises administering a therapeutically effective amount of a formulation that comprises a polyene active ingredient that includes amphotericin B, wherein the amphotericin B compound is present, in terms of polyene content, in an amount greater than 90%, and non-amphotericin B polyene compounds are present in an amount of no greater than 10%, and a pharmaceutically effective carrier; and administering a therapeutically effective amount of said formulation to a subject in need thereof.